Dean Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Hold
24,566
– – 0.77% 74
2026
Q1
$2.22M Buy
24,566
+5,038
+26% +$462K 0.92% 55
2025
Q4
$1.76M Buy
19,528
+1,960
+11% +$186K 0.75% 78
2025
Q3
$1.73M Hold
17,568
– – 0.67% 76
2025
Q2
$1.6M Buy
17,568
+941
+6% +$91K 0.66% 93
2025
Q1
$1.88M Buy
16,627
+410
+3% +$43.9K 0.82% 48
2024
Q4
$1.71M Buy
16,217
+2,473
+18% +$265K 0.73% 67
2024
Q3
$1.48M Buy
+13,744
New +$1.5M 0.63% 92
2024
Q2
– Sell
-9,501
Closed -$1.25M – 139
2024
Q1
$1.25M Hold
9,501
– – 0.73% 84
2023
Q4
$1.16M Buy
9,501
+1,541
+19% +$172K 0.71% 91
2023
Q3
$893K Buy
+7,960
New +$1.01M 0.67% 93
2021
Q1
– Sell
-4,303
Closed -$644K – 138
2020
Q4
$644K Sell
4,303
-267
-6% -$37.7K 0.38% 122
2020
Q3
$604K Sell
4,570
-1,679
-27% -$219K 0.62% 91
2020
Q2
$724K Buy
6,249
+678
+12% +$78.1K 0.85% 44
2020
Q1
$547K Buy
5,571
+219
+4% +$28.7K 0.81% 47
2019
Q4
$778K Buy
5,352
+70
+1% +$9.66K 0.74% 54
2019
Q3
$704K Sell
5,282
-219
-4% -$28.3K 0.73% 55
2019
Q2
$629K Buy
+5,501
New +$644K 0.65% 79

Other funds holding ZBH

Dean Capital Management's ZBH Position: Q2 2026 in Review

Dean Capital Management held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 24,566 shares worth $2.11M. The position accounts for 0.77% of the portfolio, ranked #74.

Dean Capital Management first reported a position in ZBH in Q2 2019 and has held it in 18 quarters since. The position peaked at $2.22M in Q1 2026. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Dean Capital Management held 24,566 shares of Zimmer Biomet worth $2.11M as of Q2 2026.
  • Dean Capital Management left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up 0.77% of Dean Capital Management's portfolio in Q2 2026, its #74 holding.
  • Dean Capital Management first reported a position in Zimmer Biomet in Q2 2019 and has held it in 18 quarters since.
  • Dean Capital Management's Zimmer Biomet position peaked at $2.22M in Q1 2026.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Dean Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.